Skip to content

Comparison of effect of Dexmedetomidine and Esmolol during Anaesthesia of Brain Tumour Surgery .

Comparative Evaluation of Fixed dose Dexmedetomidine and Esmolol Infusion as an Anaesthetic Adjuvant during Intracranial Surgery for Supratentorial Tumor: a double blind randomized study.

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2019/06/019907
Enrollment
70
Registered
2019-06-27
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: G94- Other disorders of brain in diseases classified elsewhere

Interventions

Intervention1: intravenous dexmedetomidine infusion: Dexmeditomidine infusion will be administered 1 mcg/kg in 20 min before induction[37]. . After 20 min study drug infusion, all the patients wil

Sponsors

IPGMER SSKM HospitalKolkata
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.AGEâ??20-55 YRS 2.SEXâ??either sex 3.GCSâ??14-15 4.SURGERYâ??elective intracranial surgery of a supratentorial tumour under general anaesthesia 5.ASAâ??1 to 2 6.BMI-- 7.HR-- >60/ min 8.BPâ??MAP > 80 mm hg 9. Patients or patient party willing to provide written informed consent

Exclusion criteria

Exclusion criteria: 1. Predicted difficult intubation 2. Preoperative beta blocker therapy, alpha-methyldopa,clonidine or other alpha2 agonist 3. Contraindication to beta blocker administration 4. Any history of drug abuse 5. Systemic illness such as considerable hepatic ,renal failure 6. Preoperative neurodeficit or aphasia 7. Known allergy to any of study drug 8. Uncontrolled htn, bronchial asthma, dysarrythmia including af, heart failure, cardiovascular complication, 2nd or 3rd degree heart block 9. Any pre operative haemodynamic instability 10. Pregnency 11. Any patient with difficult intubation requiring more than 20 seconds to intubate 12. Any prolonged operation ( duration > 3 hour )

Design outcomes

Primary

MeasureTime frame
changes in mean arterial pressure and heart rate Timepoint: Basal, 20 min after study drug infusion, After induction and intubation at 30 min interval up to post operative 2 hrs.

Secondary

MeasureTime frame
1. Compare the extubation time after withdrawing anesthetic and study drug 2. Pre and postoperative consciousness and sedation by HUDE Score. 3. Compare the total intraopertive propofol and fentanyl requirements 4. Any other side effects like postoperative nausea and vomiting, hypoxia and respiratory depression Timepoint: before study drug before induction 30 min after extubation

Countries

India

Contacts

Public ContactSaikat Niyogi

Bangur Institute of Neurology

saikatneuro1972@gmail.com9831732443

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026